Company news

Lg Chem Ltd. (KRX:051910) news

Lg Chem Ltd. news releases on 6ix. Latest, Sep 28, 2026: LG : Chem and Volkswagen Group Join Forces to Advance Lightweight and Sustainable Mobility Materials

View Lg Chem Ltd. →

Press releases & updates

LG : Chem and Volkswagen Group Join Forces to Advance Lightweight and Sustainable Mobility Materials

September 27, 2026

LG Chem Enters Semiconductor Stripper Market with Mass Supply to Amkor

July 16, 2026

AVEO Oncology, an LG Chem company, Announces Two Poster Presentations at ASCO 2026 Annual Meeting

May 5, 2026

Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd.

April 1, 2026

AVEO Oncology, an LG Chem company, Announces Completion of the First Interim Analysis in the Global Phase 3 FIERCE-HN Study

February 18, 2026

Palliser Capital Submits Proposal for LG Chem AGM to Address its Deep Discount and Governance Shortcomings

February 9, 2026

AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab

January 14, 2026

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets

January 13, 2026

AVEO Oncology, an LG Chem company, and HiberCell Enter Into an Exclusive Development and Option Agreement for First-in-Human Compound

November 4, 2025

Sinopec and LG Chem Sign Agreement to Jointly Develop Sodium-ion Battery Materials

November 4, 2025

ZEISS and LG Chem join forces to strengthen the photopolymer supply chain for advanced optics

October 29, 2025

LG Chem Accelerates Commercial Production of 100% Plant-Based Acrylic Acid

February 11, 2025

LG Chem LUCON® TX5007 Is Now Applied to Japanese Global OEM’s Front Fenders

January 9, 2023

LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients

July 1, 2021

LG Chem Life Sciences Announces First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States

February 22, 2021

LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions

August 18, 2020

LG Chem to Seek Innovative Technology Ideas Worldwide through 2nd Global Innovation Contest

July 25, 2019